Get started
Author

Michal Kaščák

Observed names: Kascak, Michal, Michal Kascak
ORCID: 0009-0009-1954-9021
Observed ORCID: 0009-0009-1954-9021
OpenAlex ID: A5065941962
PD ‐1/ PD ‐L1 inhibitors in haematological malignancies: update 2017
2017 · Tomas Jelinek, Jana Mihalyova, et al. · Immunology · 122
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
2022 · Irene Dogliotti, Cristina Jiménez, et al. · Leukemia · 51
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
2020 · Arne Kolstad, Tim Illidge, et al. · Blood Advances · 45
Single‐agent venetoclax induces MRD‐negative response in relapsed primary plasma cell leukemia with t(11;14)
2018 · Tomas Jelinek, Jana Mihalyova, et al. · American Journal of Hematology · 42
Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma
2018 · Tomas Jelinek, Lucie Adamusova, et al. · Bone Marrow Transplantation · 17
Venetoclax plus bortezomib and dexamethasone in heavily pretreated end‐stage myeloma patients without t(11;14): A real‐world cohort
2020 · Tomas Jelinek, Tereza Popkova, et al. · Hematological Oncology · 13
Waldenström′s macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection
2017 · Kateřina Growková, Elena Kryukova, et al. · European Journal Of Haematology · 12
PDF
Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment
2025 · Anjana Anilkumar Sithara, Veronika Kapustova, et al. · Blood Cancer Discovery · 7
PDF
Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphoma
2020 · Katarina Hradska, Michal Kascak, et al. · Expert Review of Hematology · 5
Diagnostic Tools of Waldenström’s Macroglobulinemia – Best Possibilities for Non-invasive and Long-term Disease Monitoring
2017 · Kateřina Growková, Zuzana Kufová, et al. · Klinicka onkologie · 4
Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre‐Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients
2025 · Ondrej Venglar, Eva Radova, et al. · American Journal of Hematology · 3
PDF
Ibrutinib in hematoonkology
2016 · Jana Fečková Mihályová, Juraj Ďuraš, et al. · Klinická farmakologie a farmacie · 2
PDF
Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts
2025 · Prokop Vodicka, Yucai Wang, et al. · Blood · 1
Predictive Value of Clonal Plasma Cells in Autografts Assessed By Next Generation Flow Cytometry on Pre-Transplant Bone Marrow MRD in Multiple Myeloma Patients
2024 · Ondrej Venglar, Eva Radova, et al. · Blood · 1
PDF
Practical aspects of CAR-T cell therapy
2022 · Jana Mihályová, Tomáš Jelínek, et al. · Klinicka onkologie · 1
PDF
Immune Response in 465 Hematological Patients Vaccinated with mRNA Vaccine Against SARS-CoV-2: A Single Centre Experience
2021 · Ondrej Šušol, Barbora Hájková, et al. · SSRN Electronic Journal · 1
Diagnostika a léčba Waldenströmovy makroglobulinemie
2014 · Zdeněk Adam, Roman Hájek, et al. · Transfuze a hematologie dnes · 1
Comparison of the HemoScreen Point‐Of‐Care Haematology Analyser With Sysmex XN , Beckman Coulter DxH 560 and HORIBA Yumizen H550 in Patients With Abnormal Blood Counts
2026 · Katarína Hradská, Martin Pulcer, et al. · International Journal of Laboratory Hematology
PDF
Bone marrow miRNA signatures differentiate Waldenström macroglobulinemia from multiple myeloma and reflect disease‑specific regulatory programs
2026 · Tereza Růžičková, Petra Vychytilová-Faltejsková, et al. · Scientific Reports
PDF
Survival Improvement of DLBCL Patients Treated with Third Line and Beyond in the Recent Era in the Czech Republic
2026 · Prokop Vodicka, Andrea Janikova, et al. · Blood Advances
Teclistamab in relapsed/refractory Waldenstro m macroglobulinemia
2026 · Michal Kascak, Ludmila Muronova, et al. · Haematologica
PDF
Decoding Waldenström Macroglobulinemia Through Genomics, Epigenomics and Cellular Interactions
2026 · Tereza Růžičková, Michal Kaščák, et al. · International Journal of Molecular Sciences
Figure S13 from Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment
2026 · Anjana Anilkumar Sithara, Veronika Kapustova, et al.
Table S4 from Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment
2026 · Anjana Anilkumar Sithara, Veronika Kapustova, et al.
Figure S3 from Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment
2026 · Anjana Anilkumar Sithara, Veronika Kapustova, et al.
Works count: 64
Citation count: 328
H-index: 7
I10-index: 7
Year
Topic
Type